You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

September 2002

Volume 54, Issue 3

Pages 231–338

  1. GLAXOSMITHKLINE PRIZE 2000

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
  2. Pharmacokinetics

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
    2. You have free access to this content
      Quinidine does not affect the renal clearance of moxonidine (pages 251–254)

      Stephen D. Wise, Clark Chan, Hans G. Schaefer, Minxia M. He, Isabelle J. Pouliquen and Malcolm I. Mitchell

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01647.x

      • image
    3. You have free access to this content
    4. You have free access to this content
      The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects (pages 262–268)

      Marta Boffito, Patrick G. Hoggard, Helen E. Reynolds, Stefano Bonora, E Rhiannon Meaden, Alessandro Sinicco, Giovanni Di Perri and David J. Back

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01663.x

      • image
      • image
  3. Pharmacodynamics

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
      Early clinical experience with the novel proteasome inhibitor PS–519 (pages 269–276)

      I. M. Shah, K. R. Lees, C. P. Pien and P. J. Elliott

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01638.x

      • image
      • image
      • image
    2. You have free access to this content
  4. Pharmacokinetics/pharmacodynamics

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
      Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5α-reductase inhibitor, in normal subjects treated with single or multiple doses (pages 283–294)

      Tomoe Fujita, Yoshiaki Matsumoto, Toshimi Kimura, Shinichi Yokota, Mika Sawada, Masataka Majima, Yoshio Ohtani and Yuji Kumagai

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01656.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  5. Drug disposition

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
      Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti-inflammatory drug, and its lack of clinically significant CYP inhibition potential (pages 295–303)

      Shigeru Furuta, Nobuyoshi Akagawa, Emiko Kamada, Akio Hiyama, Yoshihiro Kawabata, Nobuhiko Kowata, Atsuhiro Inaba, Anne Matthews, Michael Hall and Tadashi Kurimoto

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01649.x

      • image
      • image
      • image
      • image
  6. Drugs interaction

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
      Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin (pages 304–308)

      R. A. Faaij, J. Burggraaf, R. C. Schoemaker, R. G. M. Van Amsterdam and A.F. Cohen

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01616.x

      • image
      • image
    2. You have free access to this content
      Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin (pages 309–319)

      Teddy Kosoglou, Ingo Meyer, Enrico P. Veltri, Paul Statkevich, Bo Yang, Yali Zhu, Lillian Mellars, Stephen E. Maxwell, James E. Patrick, David L. Cutler, Vijay K. Batra and Melton B. Affrime

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01633.x

      • image
      • image
      • image
  7. Therapeutics

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
    2. You have free access to this content
      Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction (pages 327–332)

      Raymond G. Schlienger, Hershel Jick and Christoph R. Meier

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01637.x

  8. Letters to the Editors

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  9. Book reviews

    1. Top of page
    2. GLAXOSMITHKLINE PRIZE 2000
    3. Pharmacokinetics
    4. Pharmacodynamics
    5. Pharmacokinetics/pharmacodynamics
    6. Drug disposition
    7. Drugs interaction
    8. Therapeutics
    9. Letters to the Editors
    10. Book reviews
    1. You have free access to this content
      ACE inhibitors (page 337)

      N. F. Kelland and D. J. Webb

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01642.x

    2. You have free access to this content
      Introduction to proteomics (page 338)

      Version of Record online: 18 SEP 2002 | DOI: 10.1046/j.1365-2125.2002.01643.x

SEARCH

SEARCH BY CITATION